Drugs / hDNAgr
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06877377 | Sep 2025 → Feb 2026 overdue | premature aging syndrome | S.LAB (SOLOWAYS) | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hDNAgr | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06877377 ↗ |
| Action | Restore | “designed to correct or replace locally damaged genomic regions in hematopoietic stem cells” NCT06877377 ↗ |
| Modality | Other / unclassified | “fragmented therapeutic double-stranded DNA” NCT06877377 ↗ |